1 year return (CAGR)
-18.28%
Biohit Oyj B Exchange (HE, EUR)
BIOBV.HE
2.33
-0.14 (-5.58%)
HealthcareMedical Devices
Loading...
3 year return (CAGR)
5.30%
5 year return (CAGR)
3.56%
10 year return (CAGR)
-8.76%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
28.99M
Price/Sales
0.95
Ent value
31.79M
Price/Book
1.78
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
5.47
PEG
-
Forward P/E
13.94
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.51 |
| Daily high | 2.52 |
| Daily low | 2.35 |
| Daily Volume | 5K |
| All-time high | 12.20 |
| 1y analyst estimate | 3.30 |
| Beta | 0.56 |
| EPS (TTM) | 0.33 |
| Dividend per share | 0.00 |
| Ex-div date | 15 Apr 2014 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BIOBV.HE | S&P500 | |
| Current price drop from All-time high | -80.90% | -0.66% |
| Highest price drop | -92.54% | -56.47% |
| Date of highest drop | 31 Oct 2008 | 9 Mar 2009 |
| Avg drop from high | -71.39% | -10.67% |
| Avg time to new high | 670 days | 12 days |
| Max time to new high | 6543 days | 1805 days |
News
WHIPPANY, N.J., October 08, 2026--Bayer Summary
October 8, 2026
BOSTON, October 08, 2026--eClinical Solutions LLC, a global provider of digital clinical software and services, will convene global technology and biopharma leaders October 12-14 for its eighth annual...
October 8, 2026
Premium ceramics manufacturer unifies customer operations across its Dining & Lifestyle and Bathroom & Wellness divisions to deliver seamless, personalized experiences worldwidePALO ALTO, Calif. and M...
October 8, 2026
SAINT-PRIEST, France, October 08, 2026--Regulatory News: Jacquet Metals SA (Paris:JCQ):
October 8, 2026
BAYRY's Kerendia label expansion moves forward as FDA accepts an application for CKD patients without diabetes.
October 8, 2026
Novartis wins FDA approval for Rhapsido in symptomatic dermographism, expanding its chronic hives opportunity as pipeline setbacks raise pressure for growth.
October 8, 2026
WHIPPANY, N.J., October 08, 2026--Bayer today announced a partnership with actress and menopause advocate Melissa Joan Hart to increase awareness about Lynkuet® (elinzanetant) 60mg capsules, Bayer’s F...
October 8, 2026
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco...
October 8, 2026
Ahead of the openings of Frieze London and Art Basel Paris, Artprice announces the publication of its 33rd annual Contemporary Art Market Report, examining a market undergoing profound change.
October 8, 2026
135-Page Report Tracks Bayer and Merck's ADEMPAS (Riociguat) as the Leading Therapy as Combination Regimens and Balloon Pulmonary Angioplasty Reshape CTEPH TreatmentDublin, Oct. 08, 2026 (GLOBE NEWSWI...
October 8, 2026